Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients.
Van Wigcheren GF, De Haas N, Mulder TA, Horrevorts SK, Bloemendal M, Hins-Debree S, Mao Y, Kiessling R, van Herpen CML, Flórez-Grau G, Hato SV, De Vries IJM.
Van Wigcheren GF, et al. Among authors: mao y.
Oncoimmunology. 2021 Jun 27;10(1):1935557. doi: 10.1080/2162402X.2021.1935557. eCollection 2021.
Oncoimmunology. 2021.
PMID: 34239773
Free PMC article.